Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic duration in post-appendectomy abscess
NCT03795194Phase 4Terminated
- Sponsor
- Phoenix Children's
- Start
- May 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amoxicillin + clavulanate in perforated appendicitis (2 arms), sponsored by Phoenix Children's. Primary endpoints: Hospital Readmission Rate at 30 days and Length of Hospital Stay at 30 days. Started May 2019; status: terminated.
02
Drugs
amoxicillin + clavulanate
03
Conditions
perforated appendicitis
Beyond the preview
Go deeper on NCT03795194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03795194.